All Articles Tagged With: "Jaw Necrosis"
Articles
Trial Over Fosamax Jaw Damage Set to Begin April 19 in New York
A federal judge has denied attempts by Merck & Co. to have a Fosamax lawsuit thrown out, clearing the way for an April 19 trial to move forward involving allegations that the plaintiff developed permanent and debilitating jaw damage from Fosamax side effects.
Fosamax Jaw Necrosis Lawsuits in MDL Scheduled for Trial in April and June
U.S. District Judge John Keenan, who is presiding over the consolidated federal Fosamax lawsuits involving claims that the osteoporosis drug caused users to suffer debilitating jaw damage, has scheduled trial dates for “bellwether” cases to begin in April and June 2010.
Fosamax Fracture Lawsuit Remanded by MDL Judge
The judge who is presiding over the consolidated federal Fosamax litigation, which involves claims that Merck & Co. failed to warn that their osteoporosis drug may increase the risk of jaw necrosis, has ordered that one lawsuit filed by a plaintiff who alleges that she suffered hip and femur fractures from Fosamax side effects, should [...]
Jaw Damage Lawsuit Against Fosamax Dismissed Weeks Before Trial
A federal judge has dismissed a lawsuit over Fosamax, saying that the plaintiff will be unable to establish at trial that the osteoporosis drug caused her to suffer debilitating jaw damage. The case had been scheduled for trial to begin on January 12, in what was to be the second of three bellwether trials [...]
Second Fosamax Lawsuit Trial Set to Begin January 12
A firm trial date of January 12 has been scheduled for a Fosamax lawsuit against Merck & Co. over their popular osteoporosis drug, which alleges that the drug caused a woman to suffer severe and debilitating deterioration of the jaw, known as osteonecrosis of the jaw (ONJ).
Zometa Jaw Necrosis Lawsuit Results in $3.2M Verdict
A Montana jury has awarded $3.2 million to a woman who suffered debilitating jaw necrosis from Zometa, a bone strengthening drug prescribed to many cancer patients.
Zometa Lawsuit Over Jaw Necrosis Heading to Jury
A Montana jury is expected to hear closing arguments today in the first Zometa lawsuit to go to trial, involving allegations that the bone strengthening cancer drug caused a woman to develop debilitating jaw problems.
Mistrial Declared in First Fosamax Trial Over Jaw Necrosis
A federal judge has declared a mistrial in the first Fosamax lawsuit submitted to a jury over allegations that Merck & Co.’s popular osteoporosis drug causes jaw necrosis, or painful and deforming decay of the jawbone.
Jury Deliberations Continue in First Trial of Fosamax Litigation
Although jurors have indicated that they will not be able to reach an agreement in the first Fosamax trial over whether a 71 year old woman woman suffered debilitating jaw necrosis as a side effect of the osteoporosis drug, U.S. District Judge John Keenan has ordered them to continue deliberations in hopes of reaching a [...]
Fosamax Trial Underway in New York
The first of three “bellwether” Fosamax trials has begun in the U.S. District Court for the Southern District of New York in Manhattan. The case, which involves allegations that the popular osteoporosis drug Fosamax caused a painful and disfiguring jaw injury, will likely be an indicator of how juries will respond to evidence in [...]
